Comparison of extracorporal shock wave pretreatment to classic surgical delay in a random pattern skin flap model

Plastic and Reconstructive Surgery

Volumn 127, Issue 5, 2011, Pages 1830-1837

  Reichenberger, Matthias Artur ^a,b,c,d,e   Keil, Holger ^a,b,c,d,e   Mueller, Wolf ^a,b,c,d,e   Herold Mende, Christel ^a,b,c,d,e   Gebhard, Martha Maria ^a,b,c,d,e   Germann, Günter ^a,b,c,d,e   Engel, Holger ^a,b,c,d,e  

^a BG Trauma Center   (Germany)

^b Department of Plastic and Hand Surgery ^*  (Germany)

^c Institute for Pathology   (Germany)

^d Division of Neurosurgical Research   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; ENDOSCOPIC ECHOGRAPHY; GRAFT REJECTION; GRAFT SURVIVAL; MALE; METHODOLOGY; PLASTIC SURGERY; PREOPERATIVE CARE; RADIATION; RAT; SKIN TRANSPLANTATION; TIME; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HIGH-ENERGY SHOCK WAVES; MALE; PREOPERATIVE CARE; RATS; RATS, WISTAR; SKIN TRANSPLANTATION; SURGICAL FLAPS; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 79955645767     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31820cf1fb     Document Type: Article

References (26)

1. Ghali S, Butler PE, Tepper OM, et al. Vascular delay revisited. Plast Reconstr Surg. 2007;119:1735-1744. (Pubitemid 46632054)
2. Harder Y, Amon M, Laschke MW, et al. An old dream revitalised: Preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury. J Plast Reconstr Aesthet Surg. 2008;61:503-511. (Pubitemid 351635904)
3. Wang CJ. An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J. 2003;26:220-232.
4. Kuo YR, Wang CT, Wang FS, et al. Extracorporeal shock wave treatment modulates skin fibroblast recruitment and leukocyte infiltration for enhancing extended skin-flap survival. Wound Repair Regen. 2009;17:80-87.
5. Meirer R, Kamelger FS, Huemer GM, et al. Extracorporal shock wave may enhance skin flap survival in an animal model. Br J Plast Surg. 2005;58:53-57. (Pubitemid 40089681)
6. Schaden W, Fischer A, Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop Relat Res. 2001;387:90-94. (Pubitemid 32510327)
7. Kuo YR, Wang CT, Wang FS, et al. Extracorporeal shock-wave therapy enhanced wound healing via increasing topical blood perfusion and tissue regeneration in a rat model of STZ-induced diabetes. Wound Repair Regen. 2009;17:522-530.
8. Kuo YR, Wu WS, Hsieh YL, et al. Extracorporeal shock wave enhanced extended skin flap tissue survival via increase of topical blood perfusion and associated with suppression of tissue pro-inflammation. J Surg Res. 2007;143:385-392.
9. Yan X, Zeng B, Chai Y, et al. Improvement of blood flow, expression of nitric oxide, and vascular endothelial growth factor by low-energy shockwave therapy in random-pattern skin flap model. Ann Plast Surg. 2008;61:646-653.
10. Reichenberger MA, Germann G, Roth HJ, et al. Preoperative shock wave therapy reduces ischemic necrosis in an epigastric skin flap model. Ann Plast Surg. 2009;63:682-684.
11. Giunta RE, Holzbach T, Taskov C, et al. AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med. 2005;7:297-306. (Pubitemid 40443758)
12. Holzbach T, Neshkova I, Vlaskou D, et al. Searching for the right timing of surgical delay: Angiogenesis, vascular endothelial growth factor and perfusion changes in a skin-flap model. J Plast Reconstr Aesthet Surg. 2009;62:1534-1542.
13. Holzbach T, Taskov C, Neshkova I, et al. [Angiogenesis VEGF165 gene therapy with AdVEGF: A new delay procedure for flaps.] Handchir Mikrochir Plast Chir. 2005;37:365-374. (Pubitemid 43041301)
14. Meirer R, Huemer GM, Oehlbauer M, et al. Comparison of the effectiveness of gene therapy with vascular endothelial growth factor or shock wave therapy to reduce ischaemic necrosis in an epigastric skin flap model in rats. J Plast Reconstr Aesthet Surg. 2007;60:266-271. (Pubitemid 46206860)
15. Barker JH, Frank J, Bidiwala SB, et al. An animal model to study microcirculatory changes associated with vascular delay. Br J Plast Surg. 1999;52:133-142. (Pubitemid 29179106)
16. Callegari PR, Taylor GI, Caddy CM, et al. An anatomic review of the delay phenomenon: I. Experimental studies. Plast Reconstr Surg. 1992;89:397-407; discussion 417-418.
17. Morris SF, Taylor GI. The time sequence of the delay phenomenon: When is a surgical delay effective? An experimental study. Plast Reconstr Surg. 1995;95:526-533.
18. Taylor GI, Corlett RJ, Caddy CM, et al. An anatomic review of the delay phenomenon: II. Clinical applications. Plast Reconstr Surg. 1992;89:408-416; discussion 417-418.
19. Carroll CM, Carroll SM, Schuschke DA, et al. Augmentation of skeletal muscle flap survival using platelet derived growth factor. Plast Reconstr Surg. 1998;102:407-415. (Pubitemid 28366665)
20. Carroll SM, Carroll CM, Stremel RW, et al. Vascular delay and administration of basic fibroblast growth factor augment latissimus dorsi muscle flap perfusion and function. Plast Reconstr Surg. 2000;105:964-971. (Pubitemid 30158800)
21. Lineaweaver WC, Lei MP, Mustain W, et al. Vascular endothelium growth factor, surgical delay, and skin flap survival. Ann Surg. 2004;239:866-873; discussion 873-875.
22. Wong MS, Erdmann D, Sweis R, et al. Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps. Plast Reconstr Surg. 2004;113:2030-2036. (Pubitemid 39201722)
23. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389-395. (Pubitemid 30208155)
24. Helisch A, Schaper W. Angiogenesis and arteriogenesis: Not yet for prescription. Z Kardiol. 2000;89:239-244. (Pubitemid 30210343)
25. Lloyd PG, Yang HT, Terjung RL. Arteriogenesis and angiogenesis in rat ischemic hindlimb: Role of nitric oxide. Am J Physiol Heart Circ Physiol. 2001;281:H2528-H2538.
26. Aicher A, Heeschen C, Sasaki K, et al. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006;114:2823-2830. (Pubitemid 46018285)